Building Advocacy Group Relationships That Actually Send Patients
Advocacy referrals convert at unusually high rates but arrive slowly, and the usual last-minute flyer request rarely works. Here's how to build local chapter relationships that produce enrollments across multiple studies.
By Trialflow Team
Patient advocacy groups are the most underused recruitment channel at most sites. Not because coordinators don't know they exist, but because the typical approach — email the national office two weeks before first-patient-in and ask them to post your flyer — almost never works. Advocacy relationships pay off on a longer clock and with different currency than paid media.
Why advocacy referrals behave differently
In most site datasets, referrals arriving through a disease-specific organization show up as a distinct population. They tend to be better informed about their diagnosis, more likely to have records available, and far more likely to show up for the screening visit. They also tend to ask harder questions and to decline faster when the protocol doesn't fit — which is a feature, not a problem. You spend less time discovering at visit three that someone was never a candidate.
The tradeoff is volume. A local chapter will not fill a 40-patient commitment. Think of advocacy as a steady, high-conversion trickle that lowers your blended cost per enrollment, not as a surge channel.
Start with chapters, not national offices
National organizations have compliance reviews, listing criteria, and queues. They are worth pursuing for trial-listing placement, but the relationships that generate actual visits are usually local: a regional chapter coordinator, a support group facilitator, a nurse navigator who has run the same monthly meeting for eight years.
Practical sequence:
- Map what exists in your catchment area. For each therapeutic area you work in, list the condition-specific organizations, support groups, and patient-led Facebook groups within driving distance. Most sites find more than they expected.
- Reach out with no ask attached. Introduce your site, describe what you study, and offer something useful — a research-literacy talk, a Q&A on how trial phases work, a tour.
- Deliver on that offer before you ever mention a specific protocol. Credibility here is built on being useful first.
- Then share studies as they come, including ones you can't enroll. Pointing a patient toward a trial at another site is the single fastest way to become a trusted source.
What to give them
Advocacy contacts are not marketers. They need plain-language materials they can forward without editing:
- A one-paragraph description of who the study is looking for, in patient terms, not inclusion-criteria language
- What participation actually involves — visit count, time per visit, travel, procedures people care about like biopsies or lumbar punctures
- Whether travel or caregiver support is covered
- A direct phone number and a named human, not a general line
Run all of it through your IRB as recruitment material before you send it anywhere.
Keep the relationship warm between studies
The most common failure mode is going dark for a year and reappearing when a new protocol activates. Set a recurring quarterly touchpoint: a short email with any site news, an offer to speak, a note when a study you discussed reads out. Attend one meeting a quarter yourself, not a staff proxy.
Track it honestly
Tag advocacy referrals by specific organization in your source field, and review conversion separately from paid channels. A group that sends four people a year who all enroll deserves more of your time than one that generates thirty inquiries and no visits. That data also makes a strong feasibility argument: sponsors notice when a site can name its community partners and show what they produce.
Enrolling studies shouldn't be this hard
Trialflow gives research sites one platform for lead management, AI trial matching, and recruitment analytics.
Request a Demo